In this presentation, we will describe the mechanisms by which air pollution …
In this presentation, we will describe the mechanisms by which air pollution causes health effects in other parts of the body than the lungs. In continuation of this, we will discuss the important mechanisms of extra pulmonary health effect.
Case seminar text that can be used to discuss the epidemiological transition …
Case seminar text that can be used to discuss the epidemiological transition as well as to give the students a possibility to share their own experiences of working for a UN or government agency. By placing the scenario in Vietnam the students will have to read up on a country that has made great strides towards a healthier population while at the same time having to combat great disparities.
Five years after the Paris climate agreement to limit global temperature rise …
Five years after the Paris climate agreement to limit global temperature rise to “well below 2°C” the world observed a 1.2°C temperature rise above pre-industrial levels. In order to protect human health, it is imperative that efforts are made to reduce greenhouse gas emissions and keep the temperature targets agreed. The changing climate affects the conditions for human health, and the basic requirements for maintaining good health. Starting with the 2015 Lancet Commission on climate change and health that described tackling climate change as the greatest global health opportunity of the 21st century, the talk will give an overview of some health impacts covered in the Lancet Countdown and end by focusing on what the Lancet Countdown in 2020 called the often “unseen” impacts of climate change on human health – the mental health impacts.
The aim of this presentation is to address different hot topics in …
The aim of this presentation is to address different hot topics in our current understanding of aetiology as well as of the pathophysiology of Type 2 Diabetes. We’ll address how genetic as well as epi-genetic and non-genetic mechanisms may be involved in the complex mechanisms underlying type 2 diabetes. We’ll also introduce recent data suggesting that immature stem-cell functions are likely to play an important role for development of type 2 diabetes and its associated cardiometabolic disturbances. Finally we’ll address the current treatment options of disease with respect of both pharmacological and non-pharmacological treatment modalities.
Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst
This presentation address the multifactorial etiology of type 2 diabetes. The multifactorial …
This presentation address the multifactorial etiology of type 2 diabetes. The multifactorial etiology, can be divided into three major categories, primary predisposing factors, secondary precipitating factors, as well as tertiary accelerating factors.
Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst
The aim of this presentation is to address and understand the paradigm …
The aim of this presentation is to address and understand the paradigm shifting consequences of the Thrifty Phenotype Hypothesis as a conceptual framework to understand the roots of type 2 diabetes.
Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst
During the last couple of decades two new remarkably successful principles for …
During the last couple of decades two new remarkably successful principles for diabetes therapy have appeared and are now used worldwide. These are incretin based therapy and surgical therapy. These two are at some extent linked together and in this lecture we’ll provide an introduction to these two principles for diabetes therapy.
Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst
In this presentation we’ll talk about the effects of GLP-1 (Glucagon Like …
In this presentation we’ll talk about the effects of GLP-1 (Glucagon Like Peptide 1), GLP-1 has important actions on gastrointestinal secretion and motility, and it acts to inhibit appetite and food intake. In continuation of the effects of GLP-1, we’ll talk about GLP-1, GIP, lipids, proteins, and dipeptidyl peptidase-4.
Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst
This presentation talks about intravenously GLP-1 infusion to patients with type 2 …
This presentation talks about intravenously GLP-1 infusion to patients with type 2 diabetes. The GLP-1 infusion is capable of restoring fasting glucose concentrations during the night time and can nearly normalize the meal-induced glucose excursions after meal ingestion. GLP-1 has many attractive actions regarding diabetes type 2 treatment, which is the theme of this presentation.
Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst
This presentation provides an introduction to some of the basic aspects of …
This presentation provides an introduction to some of the basic aspects of the epidemiology of diabetes. In continuation of this we’ll discuss why diabetes is such a serious disease and what the biological mechanics of the disease are.
Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst
This presentation will look at how the distribution of diabetes is, thus …
This presentation will look at how the distribution of diabetes is, thus we’ll discuss how the distribution of diabetes are by type, gender, age, geographical region and ethnicity. The purpose of this discussion is to understand how serious a health problem the global epidemic of diabetes is, while increasing the understanding that it’s extremely necessary that we do whatever we can to fight against the diabetes epidemic in the future.
Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst
This presentation tries to identify the most important risk factors for developing …
This presentation tries to identify the most important risk factors for developing diabetes. In order to take the next steps in planning diabetes prevention, we need to know what distinguished those at risk of developing diabetes from those who aren’t or are at lower risk within the populations.
Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst
This presentation provides an introduction to the genetic aspects of non-autoimmune diabetes. …
This presentation provides an introduction to the genetic aspects of non-autoimmune diabetes. First we’ll introduce the genetic basis of diabetes, then we’ll talk about methods to identify genetic loci associated with diabetes and pre-diabetic traits. In continuation of this, we’ll provide examples of monogenic forms of diabetes and finally we’ll discuss common forms of non-autoimmune diabetes.
Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst
This presentation provides an introduction to methods used to identify genetic loci …
This presentation provides an introduction to methods used to identify genetic loci affecting diabetes and pre-diabetes traits. Furthermore we’ll discuss aspects that are important when choosing and considering different methods.
Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst
This presentation provides an introduction to the genetics behind the common forms …
This presentation provides an introduction to the genetics behind the common forms of type 2 diabetes. Furthermore we’ll provide an introduction to the Genome-Wide Association Study, this study is a hypothesis generating method that contains a discovery and a replication sample.
Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst
This presentations discuss diabetes as an disease of the pancreatic beta cell, …
This presentations discuss diabetes as an disease of the pancreatic beta cell, in continuation of this, we’ll discuss what causes beta cell failure in type 1 and type 2 diabetes. Furthermore we’ll discuss the innate immune system and the beta cell failure, and inflammatory mediators as therapeutic targets of type 1 and type 2 diabetes.
Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst
This presentation provides an introduction to the immune system and how it’s …
This presentation provides an introduction to the immune system and how it’s activated. In continuation of this we’ll discuss how inflammatory beta cell destruction comes about in type 1 diabetes. Furthermore we’ll discuss how beta cell failure occur in type 2 diabetes.
Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst
In this interview with Dr. Robert Ross we discuss what a successful …
In this interview with Dr. Robert Ross we discuss what a successful obesity management is and what a clinical meaningful weight loss is? Furthermore we discuss recommendations regarding physical activity for health in the general population and which strategies we should take to have people sustain physical activity in the long run.
Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst
The aim of this lecture is to give the student a new …
The aim of this lecture is to give the student a new perspective on the muscle, the largest organ in the body. Skeletal muscles are primary identified by the mechanical activity required for posture, movement and breathing, which depends on muscle fiber contractions. However skeletal muscle isn’t just a component in our locomotor system.
Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst
No restrictions on your remixing, redistributing, or making derivative works. Give credit to the author, as required.
Your remixing, redistributing, or making derivatives works comes with some restrictions, including how it is shared.
Your redistributing comes with some restrictions. Do not remix or make derivative works.
Most restrictive license type. Prohibits most uses, sharing, and any changes.
Copyrighted materials, available under Fair Use and the TEACH Act for US-based educators, or other custom arrangements. Go to the resource provider to see their individual restrictions.